PSP
REGN icon

Pacific Sage Partners’s Regeneron Pharmaceuticals REGN Stock Holding History

Pacific Sage Partners’s Portfolio REGN Stock Details REGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$238K Hold
308
– – 0.04% 106
2025
Q4 		$238K Buy
+308
New +$209K 0.04% 107
2025
Q1 		– Sell
-285
Closed -$203K – 112
2024
Q4 		$203K Hold
285
– – 0.05% 97
2024
Q3 		$300K Hold
285
– – 0.07% 79
2024
Q2 		$300K Buy
285
+1
+0.4% +$969 0.07% 76
2024
Q1 		$273K Hold
284
– – 0.07% 78
2023
Q4 		$249K Hold
284
– – 0.07% 78
2023
Q3 		$234K Hold
284
– – 0.07% 76
2023
Q2 		$204K Hold
284
– – 0.06% 82
2023
Q1 		$233K Hold
284
– – 0.08% 74
2022
Q4 		$205K Buy
+284
New +$210K 0.07% 83

Other funds holding REGN

BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.47T AUM 27.86% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return
Loomis, Sayles & Company
Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return